Search - tctmd.com

Displaying 501 - 520 of 828

Sort: Relevancy | Date

COVID-19 Autopsies Put Endothelial Damage, Angiogenesis in the Spotlight

News Daily News

COVID-19 Autopsies Put Endothelial Damage, Angiogenesis in the Spotlight

May 26, 2020

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

News Daily News

Later CVD Risk From Hypertension in Pregnancy Vastly Underestimated

May 05, 2020

Cath Lab Dispatch: April 2020

News Opinion CV Team Dispatch

April 2020 News Roundup

April 10, 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

TCTMD’s Top 10 Most Popular Stories for March 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2020

April 01, 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

April 01, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

Inclisiran Data in NEJM Prompt Talk of What Comes Next

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

March 24, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

March 17, 2020

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

March 16, 2020

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

March 10, 2020

Olive Oil Consumption Linked to CVD Benefits in the US

News Daily News

Olive Oil Consumption Linked to CVD Benefits in the US

March 09, 2020

Poor Sleepers at Higher Risk of CVD, MESA Data Suggest

News Daily News

Poor Sleepers at Higher Risk of CVD, MESA Data Suggest

March 04, 2020

Intensive BP Control Lengthens Life: SPRINT Analysis

News Daily News

Intensive BP Control Lengthens Life: SPRINT Analysis

March 03, 2020

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

News Daily News

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

February 26, 2020

Gender Gaps Persist in CV Research, Editorships, and Training

News Daily News

Gender Gaps Persist in CV Research, Editorships, and Training

Yael L. Maxwell

February 20, 2020

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

News Daily News

Study Challenges Link Between PCI Volumes and TAVR, TMVr Outcomes

February 18, 2020

ACC Releases Initial Cardiac Guidance on Novel Coronavirus

News Daily News

ACC Releases Initial Cardiac Guidance on Novel Coronavirus

February 13, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.